Peyton Thompson, MD, MSCR, Assistant Professor of Pediatrics in the Division of Infectious Diseases, is the recipient of a 2022 Early-Career Physician Scientists Award from the Doris Duke Charitable Foundation. Dr. Thompson, with her project, “Simplifying Hepatitis B Care in Pregnancy by Combining Birth-dose Vaccine and Tenofovir: The COMBAT HBV Feasibility Trial”, was one of 16 early-career physician-scientist faculty from across the nation to receive a 2022 Clinical Scientist Development Awards. The foundation funds promising physician scientists whose projects have the potential to advance the prevention, diagnosis, and treatment of human disease and to enable their transition to independent research careers.
The 2022 recipients, who will each receive grants of $495,000 over three years. The Clinical Scientist Development Awards program enables physician scientists to dedicate and protect 75% of time towards their clinical research and encourages the development of strong mentorship relations in supportive institutional environments.
A large share of this year’s recipients propose work in health outcomes, treatment and prevention, marking an increase from previous years, and span a broad range of critical health issues including, but not limited to, cardiology, telehealth care delivery, substance use disorder treatment, oncology and mental health.
To learn more about the program and this year’s awardees, visit: https://www.ddcf.org/news–insights/articles/doris-duke-charitable-foundation-announces-the-2022-clinical-scientist-development-awardees